Antibiotic treatment of acne may be associated with upper respiratory tract infections

Archives of Dermatology

Volumn 141, Issue 9, 2005, Pages 1132-1136

  Margolis, David J ^a   Bowe, Whitney P ^a   Hoffstad, Ole ^a   Berlin, Jesse A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MINOCYCLINE; OXYTETRACYCLINE; TETRACYCLINE DERIVATIVE;

ACNE; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; FEMALE; GENERAL PRACTICE; HEALTH CARE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CAUSALITY; FEMALE; HUMANS; MALE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 25444464397     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.9.1132     Document Type: Article

References (26)

1. Stern RS. Medication and medical service utilization for acne 1995-1998. J Am Acad Dermatol. 2000;43:1042-1048.
2. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(suppl):S1-S37.
3. Marples RR, Kligman AM. Ecological effect of oral antibiotics on the microflora of human skin. Arch Dermatol. 1971;103:148-153.
4. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol. 2003;139:467-471.
5. Vowels BR, Feingold DS, Sloughfy C, et al. Effects of topical erythromycin ecology of aerobic cutaneous bacterial flora. Antimicrob Agents Chemother. 1996;40:2598-2604.
6. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol. 1983;8:41-45.
7. Sanders CC, Sanders WE, Harrowe DJ. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interefere with group A streptococci. Infect Immun. 1976;13:808-812.
8. Leyden JJ. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Cutis. 2002;69:475-480.
9. Mills O Jr, Thornsberry C, Cardin CW, Smiles KA, Leyden JJ. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol. 2002;82:260-265.
10. Kaplan EL, Top FH Jr, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis. 1971;123:490-501.
11. Kaplan EL. Clinical guidelines for group A streptococcal throat infections. [comment]. Lancet. 1997;350:899-900.
12. Kaplan EL, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcal serotypes. Lancet. 2002;359:2115-2116.
13. Collins M, Fleisher GR, Fager SS. Incidence of beta hemolytic streptococcal pharyngitis in adolescent with infectious mononucleosis. J Adolesc Health Care. 1984;5:96-100.
14. Brogden KA, Guthmiller JM, Taylor CE. Human polymicrobial infections. Lancet. 2005;365:253-255.
15. Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J Occup Environ Med. 2002;44:822-829.
16. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487-494.
17. Metlay JP, Kinman J. Failure to validate pneumococcal pneumonia diagnoses in the General Practice Research Database [abstract]. Pharmacoepidemiol Drug Saf. 2003;12:S163.
18. Harrell FE Jr. Regression Modeling Strategies. New York, NY: Springer-Verlag NY Inc; 2001.
19. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2 ed. New York, NY: John Wiley & Sons Inc; 2000.
20. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125-137.
21. Haukness HA, Tanz RR, Thomson RB Jr, et al. The heterogeneity of endemic community pediatric group a streptococcal pharyngeal isolates and their relationship to invasive isolates. J Infect Dis. 2002;185:915-920.
22. Bisno AL, Kaplan EL. Appropriate use of antibiotics: pharyngitis. Ann Intern Med. 2002;136:489-490.
23. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol. 2001;167:6471-6479.
24. Dietrich G, Kolb-Maurer A, Spreng S, Schartl M, Goebel W, Gentschev I. Gram-positive and gram-negative bacteria as carrier systems for DNA vaccines. Vaccine. 2001;19:2506-2512.
25. Oberemok SS, Shalita AR. Acne vulgaris, II: treatment. Cutis. 2002;70:111-114.
26. Stern RS. Dermatologists and office-based care of dermatologic disease in the 21st century. J Investig Dermatol Symp Proc. 2004;9:126-130.